Expression of VEGF, MMP2, and RhoC in ccRCC is associated with metastasis and poor prognosis or used to evaluate the effectiveness of therapies on metastatic RCC [24-26]. Here, MMP2 is linked to nonpapillary renal cell carcinoma.